Skip to content

Presentation - Q2 2024


We invest in and build companies with pioneering pharmaceutical and biotech projects or adjacent capabilities. We differentiate ourselves by using our network, expertise and resources to achieve long-term success for our companies. We have the utmost respect for all our stakeholders and strive to be described by them as a great partner.

Latest Portfolio Company News

Latest Press Releases

Interim report Q2 2024

The interim report for the second quarter 2024 was published on Wednesday July 17 at 08:00 CEST.

Presentation: the same day at 14:00 CEST.